Slocum Gordon & Co LLP Sells 8,523 Shares of Colgate-Palmolive Company $CL

Slocum Gordon & Co LLP reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 40.8% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,373 shares of the company’s stock after selling 8,523 shares during the quarter. Slocum Gordon & Co LLP’s holdings in Colgate-Palmolive were worth $978,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of CL. Maseco LLP bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $29,000. Cloud Capital Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $30,000. Global Wealth Strategies & Associates boosted its holdings in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after buying an additional 300 shares during the period. Finally, Grove Bank & Trust boosted its holdings in shares of Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after buying an additional 263 shares during the period. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 184,683 shares of company stock worth $17,486,693. Corporate insiders own 0.43% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CL shares. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a report on Wednesday, April 8th. Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday, March 29th. Evercore upped their price objective on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, February 2nd. Citigroup increased their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Finally, UBS Group reduced their price target on shares of Colgate-Palmolive from $100.00 to $98.00 and set a “buy” rating for the company in a report on Tuesday, April 7th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $95.44.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $85.83 on Friday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The firm has a fifty day moving average price of $89.99 and a two-hundred day moving average price of $83.71. The company has a market cap of $68.86 billion, a PE ratio of 32.76, a price-to-earnings-growth ratio of 4.16 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the firm earned $0.91 EPS. The business’s revenue was up 5.8% on a year-over-year basis. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.